Home / Posters / High ICOS/FOXP3 Tregs Content in the Tumor Microenvironment is Associated with Poorer Survival in Patients with Hepatocellular Carcinoma

High ICOS/FOXP3 Tregs Content in the Tumor Microenvironment is Associated with Poorer Survival in Patients with Hepatocellular Carcinoma
2 June 2020
By Keith Bowers
OracleBio data quantifying ICOS and FoxP3 dual IHC in clinical HCC samples is presented on a collaborative poster at the AACR 2020 Virtual Annual Meeting.

The poster, produced in collaboration with Kymab and the National Taiwan University Hospital, explores the clinical significance of ICOS expression and Treg content in hepatocellular carcinoma (HCC). The poster is entitled High ICOS/FOXP3 Tregs Content in the Tumor Microenvironment is Associated with Poorer Survival in Patients with Hepatocellular Carcinoma’ and is available to view and download by clicking on the poster below:

Explore OracleBio's Scientific Posters

OracleBio's Multiplex IF Expertise

Stay up to date with OracleBio

Sign up to our mailing list to stay informed about news, webinars, events and more